Back
ESC Premium Access

Impact of plaque morphology as assessed by optical coherence tomography on procedural outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Session: Poster session 5 - Vulnerable plaque
Topic: PCI: procedural complications
Speaker: Doctor N. Braik (Evecquemont, FR)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Nassim Braik

Evecquemont Cardiology Centre, Evecquemont (France)
0 follower

18 more presentations in this session

Microvascular obstruction at cardiac magnetic resonance is a good predictor of adverse events after primary PCI for STEMI

Speaker: Associate Professor O. Rimoldi (Milan, IT)

Access
Abstract
Like
Thumbnail

Progression of atherosclerotic plaques adjacent to the edges of drug-eluting stent: a 3-time optical coherence tomography and intravascular ultrasound study

Speaker: Professor H. Jia (Harbin, CN)

Access
Abstract
Like
Thumbnail

Relation of new morphological features of culprit coronary plaques, as determined by VH-IVUS and a new computational method, with troponin elevation after coronary stenting

Speaker: Doctor T. Papaioannou (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

clinical features and vulnerable plaques at optical coherence tomography (OCT) in acute coronary syndrome (ACS): insight from the OCT-FORMIDABLE registry

Speaker: Doctor C. Moretti (Chivasso, IT)

Access
Abstract
Like
Thumbnail

Promoted plaque neovascularization in diabetic patients with peripheral arterial disease detected by contrast-enhanced intravascular ultrasound

Speaker: Mr M. Takahara (chiba-city, JP)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 5 - Vulnerable plaque

Speakers: Doctor N. Braik, Associate Professor O. Rimoldi, Professor H. Jia, Doctor T. Papaioannou, Doctor C. Moretti...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources